Endocrinology, doi:10.1210/en.2005-0324
Endocrinology Vol. 146, No. 7 3096-3104
Copyright © 2005 by The Endocrine Society
Insulin-Like Growth Factor (IGF)-I Stimulates Cell Proliferation and Induces IGF Binding Protein (IGFBP)-3 and IGFBP-5 Gene Expression in Cultured Growth Plate Chondrocytes via Distinct Signaling Pathways
Daniela Kiepe1,
Sonia Ciarmatori1,
Andreas Hoeflich,
Eckhard Wolf and
Burkhard Tönshoff
University Childrens Hospital (D.K., S.C., B.T.), 69120 Heidelberg; and Institute of Molecular Animal Breeding and Biotechnology/Gene Center (A.H., E.W.), 81377 Munich, Germany
Address all correspondence and requests for reprints to: Burkhard Tönshoff, M.D., Ph.D., University Childrens Hospital, Im Neuenheimer Feld 153, 69120 Heidelberg, Germany. E-mail: burkhard_toenshoff{at}med.uni-heidelberg.de.
The bioactivity of IGF-I in the cellular microenvironment is modulated by both inhibitory and stimulatory IGF binding proteins (IGFBPs), whose production is partially under control of IGF-I. However, little is known on the IGF-mediated regulation of these IGFBPs in the growth plate. We therefore studied the effect of IGF-I on IGFBP synthesis and the involved intracellular signaling pathways in two cell culture models of rat growth plate chondrocytes. In growth plate chondrocytes in primary culture, incubation with IGF-I increased the concentrations of IGFBP-3 and IGFBP-5 in conditioned cell culture medium in a dose- and time-dependent manner. Coincubation of IGF-I with specific inhibitors of the p42/44 MAPK pathway (PD098059 or U0126) completely abolished the stimulatory effect of IGF-I on IGFBP-3 mRNA expression but did not affect increased IGFBP-5 mRNA levels. In contrast, inhibition of the phosphatidylinositol-3 kinase signaling pathway by LY294002 abrogated both IGF-I-stimulated IGFBP-3 and -5 mRNA expression. Comparable results regarding IGFBP-5 were obtained in the mesenchymal chondrogenic cell line RCJ3.1C5.18, which does not express IGFBP-3. The IGF-I-induced IGFBP-5 gene expression required de novo mRNA transcription and de novo protein synthesis. These data suggest that IGF-I modulates its activity in cultured rat growth plate chondrocytes by the synthesis of both inhibitory (IGFBP-3) and stimulatory (IGFBP-5) binding proteins. The finding that IGF-I uses different and only partially overlapping intracellular signaling pathways for the regulation of two IGFBPs with opposing biological functions might be important for the modulation of IGF bioactivity in the cellular microenvironment.
This article has been cited by other articles:

|
 |

|
 |
 
S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, et al.
Abnormalities of Insulin-Like Growth Factor-I Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis
Endocrinology,
March 1, 2008;
149(3):
1302 - 1313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yokota, H. Shimokawa, S. Shibata, K. Itoh, Y. Baba, K. Ohya, K. Ohyama, and S. Suzuki
Insulin-like Growth Factor I Regulates Apoptosis in Condylar Cartilage
J. Dent. Res.,
February 1, 2008;
87(2):
159 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marchini, B. Hacker, T. Marttila, V. Hesse, J. Emons, B. Weiss, M. Karperien, and G. Rappold
BNP is a transcriptional target of the short stature homeobox gene SHOX
Hum. Mol. Genet.,
December 15, 2007;
16(24):
3081 - 3087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Govoni, S. K. Lee, Y.-S. Chung, R. R. Behringer, J. E. Wergedal, D. J. Baylink, and S. Mohan
Disruption of insulin-like growth factor-I expression in type II{alpha}I collagen-expressing cells reduces bone length and width in mice
Physiol Genomics,
August 20, 2007;
30(3):
354 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M Fleming, J. A Brandimarto, and W. S Cohick
The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells
J. Endocrinol.,
August 1, 2007;
194(2):
349 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Hutchison, M. H. Bassett, and P. C. White
Insulin-Like Growth Factor-I and Fibroblast Growth Factor, But Not Growth Hormone, Affect Growth Plate Chondrocyte Proliferation
Endocrinology,
July 1, 2007;
148(7):
3122 - 3130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Xian
Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth
Endocr. Rev.,
May 1, 2007;
28(3):
284 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ciarmatori, D. Kiepe, A. Haarmann, U. Huegel, and B. Tonshoff
Signaling mechanisms leading to regulation of proliferation and differentiation of the mesenchymal chondrogenic cell line RCJ3.1C5.18 in response to IGF-I
J. Mol. Endocrinol.,
April 1, 2007;
38(4):
493 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev.,
February 1, 2007;
28(1):
20 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A Meester-Smoor, A. C Molijn, Y. Zhao, N. A Groen, C. A H Groffen, M. Boogaard, D. van Dalsum-Verbiest, G. C Grosveld, and E. C Zwarthoff
The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence
J. Mol. Endocrinol.,
January 1, 2007;
38(1):
113 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Lang, B. J. Krawiec, D. Huber, J. M. McCoy, and R. A. Frost
Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2006;
290(4):
R963 - R972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kiepe, S. Ciarmatori, A. Haarmann, and B. Tonshoff
Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5
Am J Physiol Endocrinol Metab,
February 1, 2006;
290(2):
E363 - E371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Granado, T. Priego, A. I. Martin, M{a} A. Villanua, and A. Lopez-Calderon
Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle
Am J Physiol Endocrinol Metab,
December 1, 2005;
289(6):
E1007 - E1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by The Endocrine Society